Clinical trial
A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With…
NCT00231621 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Terminated
Key facts
| NCT number | NCT00231621 |
|---|---|
| Title | A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, One-year Study of the Efficacy and Safety of Topiramate in the Treatment of Obese Subjects With Dyslipidemia |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity, Hyperlipidemia, Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 179 |
| Start date | May 1, 2001 |
| Completion | Jun 1, 2002 |
| First posted | Oct 4, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: